Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
Supplement

Placebo-Controlled Double-Blind Dose-Response Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia (Including Gout Patients) in Japan

Late Phase 2 Clinical Study

Naoyuki, Kamatani MD, PhD*; Shin, Fujimori MD, PhD; Toshikazu, Hada MD, PhD; Tatsuo, Hosoya MD, PhD§; Kenjiro, Kohri MD, PhD; Toshitaka, Nakamura MD, PhD; Takanori, Ueda MD, PhD#; Tetsuya, Yamamoto MD, PhD**; Hisashi, Yamanaka MD, PhD*; Yuji, Matsuzawa MD, PhD††

Author Information
Journal of Clinical Rheumatology: June 2011 - Volume 17 - Issue 4 - p S35-S43
doi: 10.1097/RHU.0b013e31821d351d
  • Buy

Abstract

© 2011 Lippincott Williams & Wilkins, Inc.